Description
RO-7 is a next-generation polymerase (PA) endonuclease inhibitor of influenza A and B viruses.
Product information
CAS Number: 1370241-45-4
Molecular Weight: 487.49
Formula: C24H20F3N3O3S
Chemical Name: 5-hydroxy-1-[(2S)-9-thiatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaen-2-yl]-3-[(2R)-1,1,1-trifluoropropan-2-yl]-1H,2H,3H,4H,6H-pyrido[2,1-f][1,2,4]triazine-4,6-dione
Smiles: C[C@@H](N1CN([C@H]2C3=CC=CC=C3CSC3=CC=CC=C32)N2C=CC(=O)C(O)=C2C1=O)C(F)(F)F
InChiKey: XEOTUHPFOHTFEX-VLIAUNLRSA-N
InChi: InChI=1S/C24H20F3N3O3S/c1-14(24(25,26)27)28-13-30(29-11-10-18(31)22(32)21(29)23(28)33)20-16-7-3-2-6-15(16)12-34-19-9-5-4-8-17(19)20/h2-11,14,20,32H,12-13H2,1H3/t14-,20+/m1/s1
Technical Data
Appearance: Solid Power
Purity: ≥98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥12 months if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined
HS Tariff Code: 382200
How to use
In Vitro:
RO-7 is a compound that potently inhibits influenza virus replication and belongs to a new class of drugs in late-stage clinical trials for treatment of influenza virus infection. RO-7 displays broad-spectrum anti-influenza activity in vitro and protects mice from lethal challenge with both influenza A and B viruses.
In Vivo:
RO-7 protects mice from lethal challenge with both influenza A and B viruses.
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.
